Among anti-TNF-IR patients without early response , 26.5 % , 8.5 % , and 1.9 % of TCZ 8 mg/kg-randomized , TCZ 4 mg/kg-randomized , and placebo-randomized patients , respectively , achieved DAS28 3.2 at Week 24 .